NYSE | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with at least one drug therapy approved by theU. S.
Food and Drug Administration (FDA) for marketing.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| IBRX | Immunitybio Inc | Healthcare | Biotechnology | 5.06% |
| NK | NantKwest Inc | Healthcare | Biotechnology | 5.01% |
| DAWN | Day One Biopharmaceuticals Inc | Healthcare | Biotechnology | 3.87% |
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.02% |
| IOVA | Iovance Biotherapeutics Inc | Healthcare | Biotechnology | 2.95% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.81% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.77% |
| AUPH | Aurinia Pharmaceuticals Inc | Healthcare | Biotechnology | 2.71% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 2.67% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.62% |
| KALV | Kalvista Pharmaceuticals Inc | Healthcare | Biotechnology | 2.59% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 2.52% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 2.51% |
| APLS | Apellis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.49% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.34% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 2.30% |
| NVAX | Novavax Inc | Healthcare | Biotechnology | 2.26% |
| DVAX | Dynavax Technologies Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.25% |
| ROIV | Roivant Sciences Ltd | Healthcare | Biotechnology | 2.21% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 2.20% |